What is Balchem's interest income (expense), nonoperating?

Balchem (BCPC) reported interest income (expense), nonoperating of -$2.21M in Q1 2026.

How has Balchem's interest income (expense), nonoperating changed year-over-year?

Balchem's interest income (expense), nonoperating increased by 24.3% year-over-year, from -$2.92M to -$2.21M.

What is the long-term trend for Balchem's interest income (expense), nonoperating?

Over 3 years (2022 to 2025), Balchem's interest income (expense), nonoperating has grown at a -0.2% compound annual growth rate (CAGR), from -$10.27M to -$10.22M.

Balchem BCPC Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

ZoetisZTS

——

Sotera HealthSHC

——

Element SolutionsESI

——

Other financials

Income statement

See full

Revenue$270.7M+8.1%

Gross profit$101.1M+14.6%

Operating income$55.6M+9.0%

Net income$40.3M+8.7%

EPS (diluted)$1.25+10.6%

Balance sheet

See full

Cash & equivalents$72.9M+46.0%

Total debt$37.4M-1.7%

Total equity$1.3B+6.3%

Total assets$1.7B+4.7%

Cash flow

See full

Operating cash flow$40.1M+9.9%

Valuation

See full

Market cap$5.33B+0.5%

Profitability

See full

Gross margin36.3%+0.7pp

Operating margin20.2%+0.3pp

Net margin15%+0.8pp

FCF margin14.9%—

Returns & leverage

See full

Return on equity12.7%+0.7pp

Debt / equity0×0.0×

Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Balchem's interest income (expense), nonoperating?: Balchem (BCPC) reported interest income (expense), nonoperating of -$2.21M in Q1 2026.
How has Balchem's interest income (expense), nonoperating changed year-over-year?: Balchem's interest income (expense), nonoperating increased by 24.3% year-over-year, from -$2.92M to -$2.21M.
What is the long-term trend for Balchem's interest income (expense), nonoperating?: Over 3 years (2022 to 2025), Balchem's interest income (expense), nonoperating has grown at a -0.2% compound annual growth rate (CAGR), from -$10.27M to -$10.22M.